Serum methionine adenosyltransferase 1A (MAT1A) levels and hepatic Mat1a gene expressions were downregulated in NAFLD patients compared with healthy control [52,53,54]. Here, MAT1A is linked to metabolic dysfunction-associated steatotic liver disease.